HDAC1 and neoplasm: In turn, hydroxamic acids containing a bicyclic pinane framework in the cap group inhibit HDAC1 of tumor cells, due to their high affinity for HDAC1, due to the formation of hydrogen bonds with the enzyme allosteric center [52].